• Cohu, Inc. recently reported that a semiconductor manufacturer placed multiple orders totaling approximately US$5,000,000 for its DiamondX test platform, which supports high‑current, ultra‑low resistance measurements and scalable multi‑site throughput for gallium nitride power devices in AI data center power architectures.
• This win highlights how Cohu is tying its advanced power test capabilities directly to the specific needs of AI data center power conversion, from AC‑DC front ends to point‑of‑load management.
• We’ll now explore how this DiamondX GaN power device win may influence Cohu’s investment narrative around AI infrastructure and advanced test solutions.

AI is about to change healthcare. These 33 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

Cohu Investment Narrative Recap

To own Cohu, you need to believe its test platforms can stay essential as AI data center and power electronics requirements become more complex, while the business works through semiconductor cycles and current losses. The US$5,000,000 DiamondX GaN order supports the AI infrastructure angle by tying Cohu to power conversion inside AI data centers, but does not remove key near term risks around customer concentration, qualification timing for new platforms and the volatility that comes with an unprofitable, highly cyclical end market mix.

Against that backdrop, the recent shareholder vote to increase authorized common shares from 90 million to 150 million and approve new equity and employee stock purchase plans is worth watching. It sits alongside ongoing ESOP related shelf registrations and could matter for investors who are already weighing catalysts such as growing AI and HPC exposure against risks like underutilized capacity, elevated R&D and potential dilution while earnings remain negative.

Yet behind the AI test wins and product momentum, one risk investors should be aware of is that Cohu’s growing customer concentration means...

Cohu's narrative projects $817.1 million revenue and $48.9 million earnings by 2029. This requires 19.3% yearly revenue growth and a $104.4 million earnings increase from -$55.5 million today.

Uncover how Cohu's forecasts yield a $57.43 fair value, a 26% upside to its current price.

Exploring Other Perspectives

Before this DiamondX AI power-device win, the most pessimistic analysts were still assuming about 17.2% annual revenue growth and earnings of US$36.6 million by 2029, yet they worried that heavy focus on AI handlers tied to a few large programs could leave Cohu with underused capacity if spending cools, so this new order may or may not shift that more cautious story.

Explore 2 other fair value estimates on Cohu - why the stock might be worth as much as 67% more than the current price!

Decide For Yourself

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Cohu research is our analysis highlighting 4 key rewards that could impact your investment decision.
• Our free Cohu research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Cohu's overall financial health at a glance.

Ready To Venture Into Other Investment Styles?

Our top stock finds are flying under the radar-for now. Get in early:

• Uncover the next big thing with 28 elite penny stocks that balance risk and reward.
• Capitalize on the AI infrastructure supercycle with our selection of the 46 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 27 best rare earth metal stocks of the very few that mine this essential strategic resource.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.